glutathione treatment and parkinson& 39

glutathione treatment and parkinson& 39 S-transferase: A keystone in Parkinson's disease pathogenesis therapy Enhanced accumulation of reduced glutathione

Name: glutathione treatment and parkinson& 39 S-transferase: A keystone in Parkinson's disease pathogenesis therapy Enhanced accumulation of reduced glutathione
Brand: cantondelareina.com.ar
SKU: 27008484611
Price: 23.68 USD
Availability: InStock
Rating: 4.4707 (20 reviews)

Enhanced accumulation of reduced glutathione by Scopoletin improves survivability of dopaminergic neurons in Parkinson's model Cell Death & Disease Frontiers Understanding Parkinson's disease: current trends and its multifaceted complications Frontiers Role and mechanism of molecular hydrogen in the treatment of Parkinson's diseases Gut microbiota and Parkinson's disease: exploring pathogenesis and potential therapeutic strategies from a gut brain axis perspective ScienceDirect

SKU: 27008484611 · From cantondelareina.com.ar

4.5

USD23.68 USD72.68

Pay in 4 interest-free payments of $5.92 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 13 - Aug 18

Description

Fecal microbiota transplantation exerts a protective role in MPTP-induced Parkinsons disease via the TLR4/PI3K/AKT/NF-B pathway stimulated by -synuclein

Alterations in the gut microbiome may influence the expression and activity of the sodium/iodine symporter (NIS), a protein essential for iodine transport into thyroid follicular cells (Nicola et al., 2009)